Human Immunodeficiency Virus (HIV) Market 2019 Strategic Assessments – Johnson & Johnson, Merck and Co., Gilead and GlaxoSmithKline Plc.
The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures.
View full press release